Jan-Rung Mo

An inhibitor of Janus kinase 2 prevents polycythemia in mice.

M. Scott, N. Kohl, M. Kraus, 2009, Biochemical pharmacology.

Splenectomy Normalizes Hematocrit in Murine Polycythemia Vera

D. Gargano, Shuxia Zhao, M. Angagaw, 2009, PloS one.

PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity.

Tim J. Wigle, M. Niepel, K. Swinger, 2021, Cancer cell.

The discovery of tricyclic pyridone JAK2 inhibitors. Part 1: hit to lead.

T. Rush, M. Altman, Joon Jung, 2010, Bioorganic & medicinal chemistry letters.

Efficacious Intermittent Dosing of a Novel JAK2 Inhibitor in Mouse Models of Polycythemia Vera

Shuxia Zhao, Joe Zhu, Lin Xu, 2012, PloS one.

Thiophene carboxamide inhibitors of JAK2 as potential treatments for myleoproliferative neoplasms.

Thomas Rush, Andrew M Haidle, Michael D Altman, 2014, Bioorganic & medicinal chemistry letters.

Molecular Pathogenesis of Genetic and Inherited Diseases Progranulin Is a Chemoattractant for Microglia and Stimulates Their Endocytic Activity

J. Crispino, Heike Hering, L. M. Camargo, 2010 .

A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explants.

M. Niepel, K. Swinger, K. Kunii, 2021, Cell chemical biology.

Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.

M. Niepel, B. Gui, R. Abo, 2019, Biochemical pharmacology.

Transforming growth factor β1 induction of vascular endothelial growth factor receptor 1: Mechanism of pericyte-induced vascular survival in vivo

Lois E. H. Smith, S. Shih, J. Ney, 2003, Proceedings of the National Academy of Sciences of the United States of America.